Healthcare -
Biotechnology - NASDAQ - US
$ 3.57
2.29 %
$ 1.86 M
Market Cap
-0.01
P/E
REVB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities REVB - Revelation Biosciences, Inc.
14 M
LAST VALUE
32.37%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR